Form 425 HISTOGENICS CORP Filed by: HISTOGENICS CORP
Filed by Histogenics Corporation pursuant to
Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-6
under the Securities Exchange Act of 1934
Subject Company: Histogenics Corporation (SEC File No. 001-36751)
Commission File No. for the Related Registration Statement: 333-232147
August 29, 2019
Dear Stockholder:
The September 12, 2019 Special Meeting of Stockholders of Histogenics Corporation in connection with the proposed merger with Ocugen, Inc. is fast approaching, and according to our latest records, we have not received your vote. Your Board of Directors unanimously recommends that stockholders vote FOR the merger and related proposals on the agenda.
THE MERGER CANNOT BE CONSUMMATED WITHOUT THE APPROVAL OF PROPOSAL NOS. 1 AND 2. Therefore, your vote is important, no matter how many or how few shares you may own.
To make sure your shares are represented at the special meeting, we encourage you to vote today by telephone or by Internet.
Very truly yours,
Adam Gridley
President
Histogenics Corporation
REMEMBER:
You can vote your shares via the Internet.
Please follow the easy instructions on the enclosed proxy card.
If you have any questions, or need assistance in voting
your shares, please call our proxy solicitor:
INNISFREE M&A INCORPORATED
TOLL-FREE, at 1-877-456-3402.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GA-ASI Selected to Build CCA for AFLCMC
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Compass Minerals International, Inc. with Losses to Contact the Firm
- Pulse Seismic Inc. Reports Q1 2024 Results and Increases Regular Dividend
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!